Onyx (ONXX) volatility flat into Kyprolis FDA panel vote

Onyx Pharmaceutical (Nasdaq: ONXX) overall option implied volatility of 50 is near its 26-week average of 53 according to Track Data, suggesting non-directional price movement as shares are halted into a FDA panel vote for Kyprolis.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BJ's Wholesale Club (BJ) call put ratio 1.3 calls to 1 put into quarter results
• Royal Caribbean (RCL) call put ratio 1 call to 1.8 puts amid price movement
• Sandisk (SNDK) call put ratio 1.2 calls to 1 put